Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.

The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in February 2019.

Parkinson's UK announces partnership with the Insight Into Parkinson's summit 2019.

A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.

We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.

Researchers at the University of Edinburgh have used cutting-edge gene-editing techniques to create stem cells that are resistant to developing Parkinson’s.

We're streamlining and speeding up our project grant review process.

A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.

European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.

Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.